FGFR1 and breast carcinoma: Nuclear FGFR1 has been implicated in promoting the proliferation and invasion of pancreatic cancer cells [70], activating the transcription of genes crucial for the migration of breast cancer cells, and driving the expression of genes associated with resistance to anti-estrogen therapy in ER + breast cancer, contributing to poor patient prognosis [71].